SPIN-OFF FROM LUMIBIRD INTO QUANTEL TECHNOLOGIES

Ledouble acting as independent expert in the context of the public buyout offer followed by a squeeze-out to be launched by EB Development on Eurobio Scientific shares

Ledouble acting as independent expert in the context of the mandatory tender offer to be launched by Thales on Exail Technologies shares and ODIRNANE bonds

Transcript of remarks made at the event organised on 23 June 2026 by ADB (Association des Avocats en Droit Boursier)